About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Georgia | 690 Studies

Clinical Trials Breast CancerGeorgia

Breast Cancer Clinical Trials in Georgia

Find 690 clinical trials for breast cancer near Georgia. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 690 trials

CompletedA Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerThe purpose of this study is to evaluate the biological effects of abemaciclib in combination with anastrozole and compare those to the effects of abemaciclib alone and…NCT02441946·Bakersfield, California and 65 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingLetrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast CancerThis early phase I trial tests whether letrozole with simvastatin works better than letrozole alone to stop tumor cell proliferation in patients with stage I-III hormone receptor…NCT05464810·Atlanta, Georgia and 3 others

RecruitingA Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast CancerThe goal of this clinical study is to learn more about the study drug sacituzumab govitecan-hziy (SG) given at an alternative dose and schedule, in participants with…NCT06926920·Los Angeles, California and 15 others

Active not recruitingBreast Cancer WEight Loss Study (BWEL Study)This randomized phase III trial compares whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence).NCT02750826·Daphne, Alabama and 1497 others

RecruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsThis is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2.NCT05150691·Cerritos, California and 101 others

TerminatedEndoPredict® Extended Endocrine Trial (EXET)The purpose of this study is to evaluate the impact of using EndoPredict® clinically to inform treatment decisions for extended endocrine therapy, and the subsequent impact on…NCT04016935·Burbank, California and 51 others

TerminatedIsoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or LumpectomyRATIONALE: Eating a diet rich in soy foods may slow the progression of some types of cancer.NCT00036686·Phoenix, Arizona and 6 others

CompletedAn Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and LoperamideAn Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide or other…NCT02400476·Birmingham, Alabama and 57 others

CompletedS0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the BoneRATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00410813·Mobile, Alabama and 116 others

TerminatedA Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast CancerThe reason for this study is to compare the efficacy of abemaciclib, in combination with fulvestrant, to that of physician's choice of chemotherapy in women with hormone…NCT04031885·Avondale, Arizona and 60 others

RecruitingFirst-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for CancerThis study is a first in human, two-stage single arm non-comparative study of safety and performance.NCT05460780·Strasbourg, France and 2 others

TerminatedInteraction of Docetaxel and Lonafarnib in Patients With Advanced CancerTo determine the molecular interaction in tumor samples between docetaxel and lonafarnib.NCT00288444·Atlanta, Georgia

RecruitingDe-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor…NCT04852887·Birmingham, Alabama and 831 others

CompletedEGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast CancerRATIONALE: Chemotherapy may cause memory loss, attention loss, and other problems that make it difficult for patients to think clearly.NCT00046891·Scottsdale, Arizona and 174 others

CompletedA Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and…NCT03517488·Los Angeles, California and 16 others

Active not recruitingStudy to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast CancerStudy LAE205INT3101 is a Phase Ib/III study to evaluate the efficacy and safety of the combination therapy with afuresertib plus fulvestrant (afuresertib/placebo plus fulvestrant…NCT04851613·Santa Monica, California and 54 others

Active not recruitingCone Beam Breast CT for Breast Cancer ScreeningUp to one thousand and twenty-eight (1028) patients from screening and diagnostic population will be enrolled and consented to participate in the study to create an enriched data…NCT05036096·Port Orange, Florida and 3 others

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

RecruitingPropranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast CancerThis phase II trial tests how well propranolol and pembrolizumab work to cause tumor re-sensitization and therefore treatment in patients with triple negative breast cancer that…NCT05741164·Atlanta, Georgia and 1 other

Active not recruitingTesting Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain MetastasesThis phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases).NCT04647916·Anchorage, Alaska and 295 others

PreviousPage 10 of 35Next

Other Conditions in Georgia

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma